SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-008126
Filing Date
2019-03-18
Accepted
2019-03-18 08:05:46
Documents
5
Period of Report
2019-03-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K (CFO RESIGNATION) prtk-8k_20190318.htm 8-K 32647
2 EX-10.1 prtk-ex101_7.htm EX-10.1 166247
3 EX-99.1 prtk-ex991_6.htm EX-99.1 15640
4 GRAPHIC gcgt4vj00fl3000001.jpg GRAPHIC 5909
5 GRAPHIC giwr5mvowwcx000001.jpg GRAPHIC 13217
  Complete submission text file 0001564590-19-008126.txt   242608
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Filer) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36066 | Film No.: 19686867
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1